Heading: |
Prostate Cancer: Health Services |
Question ID: |
1785933 |
UIN: |
39202 |
House: |
Commons |
Date tabled: |
2025-03-18 |
Asking Member ID: |
5111 |
Asking Member display name: |
Martin Wrigley
|
Asking Member handle: |
|
Asking Member Twitter reference: |
Martin Wrigley
|
Member interest: |
false |
Question text: |
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 17 March 2025 to Question 36892 on Prostate Cancer: Health Services, if he will make an assessment of the adequacy of the (a) time taken and (b) effectiveness of treatment |
Is named day: |
false |
Date of holding answer: |
|
Date answered: |
2025-03-28 |
Date answer corrected: |
|
Is holding answer: |
false |
Is correcting answer: |
false |
Answering Member ID: |
4981 |
Answering Member display name: |
Ashley Dalton
|
Answering Member handle: |
AshleyDalton_MP
|
Answering Member Twitter reference: |
@AshleyDalton_MP
|
Correcting Member ID: |
|
Correcting Member display name: |
|
Correcting Member handle: |
|
Correcting Member Twitter reference: |
|
Answer text: |
Routine Prostate Specific Antigen (PSA) testing is not offered on the National Health Service, although men aged 50 years old or over can ask their general practitioner for a PSA test, even if they do not have symptoms. This applies to anyone aged 50 year... |
Original answer text: |
|
Comparable answer text: |
|
Answering body ID: |
17 |
Answering body name: |
Department of Health and Social Care |
Tweeted: |
true |